News | March 25, 2026
FDA nod to Johnson & Johnson’s oral psoriasis therapy 'ICOTYDE'
New targeted pill offers hope for adults and teens with moderate-to-severe plaque psoriasis
New targeted pill offers hope for adults and teens with moderate-to-severe plaque psoriasis
The announcement marks Dr. Reddy’s Day?1 entry into the GLP?1 receptor agonists therapy space and readiness to serve patients in India
These upgrades will enable advanced development and flexible manufacturing, supporting complex therapeutics and meeting global demand for advanced pharmaceutical solutions
The expanded program allows patients to fill prescriptions either at a local pharmacy or through home delivery via LillyDirect
Neupharma gains exclusive rights to develop and commercialize corticorelin for peritumoral brain edema
The new LEED Gold-certified building will serve as CordenPharma Colorado’s sole tenant
Achondroplasia, a rare genetic disorder, causes skeletal dysplasia and often increases the risk of muscular, neurological, and cardiorespiratory complications
Under the deal, Vivtex will license select oral drug-delivery technologies to Novo Nordisk
One of India’s top integrated contract research, development, and manufacturing organizations (CRDMOs) is on a hiring spree
This transaction fundamentally strengthens Scinai's CDMO platform
Subscribe To Our Newsletter & Stay Updated
